SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-13-067286
Filing Date
2013-12-13
Accepted
2013-12-13 18:06:43
Documents
1
Period of Report
2013-12-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v363086_3.html 3  
1 OWNERSHIP DOCUMENT v363086_3.xml 3 1550
  Complete submission text file 0001144204-13-067286.txt   3149
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
FEINSTEIN RICHARD L (Reporting) CIK: 0001214589 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-12957 | Film No.: 131277334